Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D7HU
|
||||
Former ID |
DNC014006
|
||||
Drug Name |
7-Phenyl-1-(2H-tetrazol-5-yl)-heptan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529594] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H18N4O
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NNN=N2
|
||||
InChI |
1S/C14H18N4O/c19-13(14-15-17-18-16-14)11-7-2-1-4-8-12-9-5-3-6-10-12/h3,5-6,9-10H,1-2,4,7-8,11H2,(H,15,16,17,18)
|
||||
InChIKey |
JVOYAZCLPXVADL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529594] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.